Trial · NCT01554956
Results by group102
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 102
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_mITT | success | 75 | 95% Confidence Interval 19.4 to 99.4 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_mITT | success | 81.8 | 95% Confidence Interval 48.2 to 97.7 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_PP | success | 100 | 95% Confidence Interval 29.2 to 100 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_PP | success | 100 | 95% Confidence Interval 66.4 to 100 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_mITT | partial success | 0 | 95% Confidence Interval 0 to 60.2 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_mITT | partial success | 18.2 | 95% Confidence Interval 2.3 to 51.8 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_PP | partial success | 0 | 95% Confidence Interval 0 to 70.8 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_PP | partial success | 0 | 95% Confidence Interval 0 to 33.6 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_mITT | failure | 25 | 95% Confidence Interval 0.6 to 80.6 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_mITT | failure | 0 | 95% Confidence Interval 0 to 28.5 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1A_PP | failure | 0 | 95% Confidence Interval 0 to 70.8 | percentage of eyes |
| Percentage of Success to Prevent Pseudomembranes Relapse | Group 1B_PP | failure | 0 | 95% Confidence Interval 0 to 33.6 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_ mITT | complete success | 20 | 95% Confidence Interval 4.3 to 48.1 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_PP | complete success | 25 | 95% Confidence Interval 5.5 to 57.2 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_ mITT | partial success | 46.7 | 95% Confidence Interval 21.3 to 73.4 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_PP | partial success | 58.3 | 95% Confidence Interval 27.7 to 84.8 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_ mITT | failure | 33.3 | 95% Confidence Interval 11.8 to 61.6 | percentage of eyes |
| Percentage of Eyes With Regression in Surface Area of Existing Ligneous Pseudomembranes | Group 1_PP | failure | 16.7 | 95% Confidence Interval 2.1 to 48.4 | percentage of eyes |
| Number of Subjects Who Experience Signs and Symptoms of Sensitization. | Group 1A_Safety Population | Number of Subjects with Ocular Adverse Events | 1 | number of subjects | |
| Number of Subjects Who Experience Signs and Symptoms of Sensitization. | Group 1B_Safety Population | Number of Subjects with Ocular Adverse Events | 4 | number of subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01554956/results